Cas:22508-64-1 4-Methyl-4-penten-1-ol manufacturer & supplier

We serve Chemical Name:4-Methyl-4-penten-1-ol CAS:22508-64-1 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

4-Methyl-4-penten-1-ol

Chemical Name:4-Methyl-4-penten-1-ol
CAS.NO:22508-64-1
Synonyms:4-Methylpent-4-ene-1-ol;4-Methylpent-4-en-1-ol;4-Penten-1-ol,4-methyl;4-Penten-1-ol, 4-methyl-;4-Methyl-4-penten-1-ol;EINECS 245-046-4
Molecular Formula:C6H12O
Molecular Weight:100.159
HS Code:2905290000

Physical and Chemical Properties:
Melting point:N/A
Boiling point:147.3±9.0 °C at 760 mmHg
Density:0.8±0.1 g/cm3
Index of Refraction:1.429
PSA:20.23000
Exact Mass:100.088814
LogP:1.57

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like 4-Methylpent-4-ene-1-ol chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,EINECS 245-046-4 physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,4-Penten-1-ol, 4-methyl- Use and application,EINECS 245-046-4 technical grade,usp/ep/jp grade.


Related News: The Breakthrough Designation for the iLet Bionic Pancreas System contemplates configurations with most insulin analogs approved for pumping as well as dasiglucagon, Zealand Pharma��s stable pumpable glucagon analog, which has a unique stability profile in a ready-to-use aqueous solution. 4-Methyl-4-penten-1-ol manufacturer Beta Bionics, Inc. recently announced it has received Breakthrough Device designation from the US FDA for its investigational iLet Bionic Pancreas System. 4-Methyl-4-penten-1-ol supplier British Airways, Qantas and Lufthansa — among others — have announced they will stop flying to mainland China. Other airlines are reducing the number of flights. 4-Methyl-4-penten-1-ol vendor The Breakthrough Designation for the iLet Bionic Pancreas System contemplates configurations with most insulin analogs approved for pumping as well as dasiglucagon, Zealand Pharma��s stable pumpable glucagon analog, which has a unique stability profile in a ready-to-use aqueous solution. 4-Methyl-4-penten-1-ol factory The Breakthrough Designation for the iLet Bionic Pancreas System contemplates configurations with most insulin analogs approved for pumping as well as dasiglucagon, Zealand Pharma��s stable pumpable glucagon analog, which has a unique stability profile in a ready-to-use aqueous solution.